Data from French trial should inform treatment decisions in the majority of lung cancer patients aged 70 and up.
Mary Beth Nierengarten
Advertisement
Articles by Mary Beth Nierengarten
Advertisement
Latest Updated Articles
Doublet Chemo Proves Superior to Single-agent Therapy in Older Patients with Advanced Non-small-cell Lung CancerPublished: August 9th 2010 | Updated:
Advertisement
Advertisement
Trending on CGTlive®
1
FDA Decisions to Look For in 1H 2026
2
Ultragenyx Finishes Rolling Submission of BLA for Glycogen Storage Disease Gene Therapy DTX401
3
Integrating AI Tools Into Clinical Practice for Genetic Counselors
4
Pillars of Progress: Top News in Oncology From 2025
5